61895-34-9 Usage
Uses
Used in Pharmaceutical Industry:
5,8-Quinolinediamine, 6-methoxyis used as a building block in the synthesis of pharmaceuticals for its potential role in the development of new drugs. Its unique chemical structure allows for the creation of compounds with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, 5,8-Quinolinediamine, 6-methoxyis utilized as a precursor in the production of agrochemicals, contributing to the development of pesticides and other agricultural chemicals that can enhance crop protection and yield.
Used in Dye Industry:
5,8-Quinolinediamine, 6-methoxyis employed in the dye industry as a key component in the synthesis of various dyes. Its chemical properties enable the creation of dyes with specific color characteristics and stability.
Used in Research and Development:
5,8-Quinolinediamine, 6-methoxyis also used in research and development settings for exploring its biological activities, such as anti-inflammatory and anti-microbial properties, which can lead to the discovery of new therapeutic agents and treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 61895-34-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,8,9 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 61895-34:
(7*6)+(6*1)+(5*8)+(4*9)+(3*5)+(2*3)+(1*4)=149
149 % 10 = 9
So 61895-34-9 is a valid CAS Registry Number.
61895-34-9Relevant academic research and scientific papers
Quinoline quinones and anti-asthmatic use thereof
-
, (2008/06/13)
This invention relates to a class of quinoline quinones, which are useful for the therapy of immediate hypersensitivity reactions, such as asthma, and in treating any condition characterized by excessive release of leukotrienes. This invention also includes a method for treating these conditions, which comprises administering to animals, including humans, an effective dose of the quinoline quinone compounds. A further part of this invention is pharmaceutical formulations containing these pharmacologically-active compounds.
